Lombard Odier Asset Management (Europe)’s Teva Pharmaceuticals TEVA Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,357	Closed	-$93K	–	376
2020 Q3	$93K	Hold	10,357	–	–	0.01%	353
2020 Q2	$128K	Hold	10,357	–	–	0.02%	128
2020 Q1	$93K	Hold	10,357	–	–	0.01%	286
2019 Q4	$101K	Hold	10,357	–	–	0.01%	403
2019 Q3	$71K	Hold	10,357	–	–	0.01%	387
2019 Q2	$96K	Hold	10,357	–	–	0.01%	393
2019 Q1	$162K	Hold	10,357	–	–	0.02%	360
2018 Q4	$160K	Hold	10,357	–	–	0.01%	341
2018 Q3	$223K	Hold	10,357	–	–	0.02%	355
2018 Q2	$252K	Buy	+10,357	New	+$211K	0.02%	303
2017 Q4	–	Sell	-11,059	Closed	-$195K	–	463
2017 Q3	$195K	Hold	11,059	–	–	0.01%	426
2017 Q2	$367K	Hold	11,059	–	–	0.02%	268
2017 Q1	$355K	Sell	11,059 -2,273	-17%	-$77.6K	0.02%	247
2016 Q4	$483K	Buy	+13,332	New	+$532K	0.17%	151
2015 Q1	–	Sell	-17,013	Closed	-$978K	–	161
2014 Q4	$978K	Buy	+17,013	New	+$948K	0.21%	67

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s TEVA Position: Q4 2020 in Review

Lombard Odier Asset Management (Europe) sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 10,357 shares — an estimated $93K sold.

Lombard Odier Asset Management (Europe) first reported a position in TEVA in Q4 2014 and held it in 15 quarters. The position peaked at $978K in Q4 2014. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

Lombard Odier Asset Management (Europe) reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Lombard Odier Asset Management (Europe) sold 10,357 Teva Pharmaceuticals shares in Q4 2020, an estimated $93K.
Lombard Odier Asset Management (Europe) first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 15 quarters.
Lombard Odier Asset Management (Europe)'s Teva Pharmaceuticals position peaked at $978K in Q4 2014.
450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q4 2020, filed 16 Feb 2021.